Switch theme
Sign up to access all valuation multiples
MRSO Inc is a company who operates a healthcare platform and provides vertical SaaS for medical, government and corporations. It is also largest preventive medical platform for making reservations for medical checkups and various cancer screenings. They provide administrative DX services that support various tasks carried out by local governments, such as accepting reservations for resident health checkups and vaccinations. The administrative DX services provided by MRSO are used by local governments in a wide range of regions and population sizes.
2015
n/a
LTM Revenue $8.9M
LTM EBITDA n/a
$9.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MRSO has a last 12-month revenue of $8.9M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, MRSO achieved revenue of $8.9M and an EBITDA of $1.1M.
MRSO expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MRSO valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $12.0M | $8.9M | XXX | XXX | XXX |
| Gross Profit | $11.9M | $9.6M | XXX | XXX | XXX |
| Gross Margin | 99% | 109% | XXX | XXX | XXX |
| EBITDA | $4.1M | $1.1M | XXX | XXX | XXX |
| EBITDA Margin | 34% | 12% | XXX | XXX | XXX |
| Net Profit | $4.3M | $2.6M | XXX | XXX | XXX |
| Net Margin | 36% | 29% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MRSO's stock price is JPY 897 (or $6).
MRSO has current market cap of JPY 3.2B (or $21.2M), and EV of JPY 1.4B (or $9.2M).
See MRSO trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9.2M | $21.2M | XXX | XXX | XXX | XXX | $0.19 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MRSO has market cap of $21.2M and EV of $9.2M.
MRSO's trades at 1.0x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate MRSO's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MRSO and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $9.2M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 8.5x | XXX | XXX | XXX |
| P/E | 31.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -17.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMRSO's NTM/LTM revenue growth is -100%
MRSO's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, MRSO's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MRSO's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MRSO and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -26% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -73% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 65% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MRSO acquired XXX companies to date.
Last acquisition by MRSO was XXXXXXXX, XXXXX XXXXX XXXXXX . MRSO acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MRSO founded? | MRSO was founded in 2015. |
| Where is MRSO headquartered? | MRSO is headquartered in Japan. |
| Is MRSO publicy listed? | Yes, MRSO is a public company listed on TKS. |
| What is the stock symbol of MRSO? | MRSO trades under 5619 ticker. |
| When did MRSO go public? | MRSO went public in 2023. |
| Who are competitors of MRSO? | Similar companies to MRSO include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of MRSO? | MRSO's current market cap is $21.2M |
| What is the current revenue of MRSO? | MRSO's last 12-month revenue is $8.9M. |
| What is the current EV/Revenue multiple of MRSO? | Current revenue multiple of MRSO is 1.0x. |
| What is the current revenue growth of MRSO? | MRSO revenue growth between 2023 and 2024 was -26%. |
| Is MRSO profitable? | Yes, MRSO is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
